Carcinogens and Oncogenes — Core Principles
Core Principles
Cancer arises from uncontrolled cell growth, a process often initiated or promoted by carcinogens and driven by oncogenes. Carcinogens are agents—physical (like UV light, X-rays), chemical (like tobacco smoke, asbestos), or biological (like HPV, Hepatitis viruses)—that damage DNA or disrupt cellular processes, leading to mutations.
These mutations can activate proto-oncogenes, which are normal genes regulating cell growth, into oncogenes. Oncogenes act like a stuck accelerator, constantly signaling cells to divide. Mechanisms of oncogene activation include point mutations (e.
g., *RAS*), gene amplification (e.g., *HER2*), chromosomal translocations (e.g., *BCR-ABL*), and viral insertions. The development of cancer typically involves the accumulation of such genetic alterations, often coupled with the inactivation of tumor suppressor genes, which normally act as cellular brakes.
Understanding these agents and genes is crucial for cancer prevention, diagnosis, and targeted therapies.
Important Differences
vs Oncogene
| Aspect | This Topic | Oncogene |
|---|---|---|
| Nature | Normal cellular gene | Mutated or overexpressed proto-oncogene |
| Function | Regulates and promotes normal cell growth, division, and differentiation (cellular 'accelerator') | Promotes uncontrolled cell growth and division, contributing to cancer (stuck 'accelerator') |
| Genetic Change | No mutation or normal expression level | Gain-of-function mutation, gene amplification, chromosomal translocation, or viral insertion |
| Role in Cancer | Essential for normal physiological processes; does not cause cancer | Directly drives cancerous transformation and progression |
| Effect on Cell | Controlled proliferation and differentiation | Uncontrolled proliferation, reduced apoptosis, altered differentiation |
| Examples | *c-RAS*, *c-MYC*, *c-HER2* | *v-RAS*, *v-MYC*, amplified *HER2*, *BCR-ABL* |